Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gds Regulatory News (SMSD)

Share Price Information for Samsung El.gds (SMSD)

Share Price is delayed by 15 minutes
Get Live Data
3,335.00    85.00 (2.62%)
Bid:
3,320.00
Ask:
3,335.00
Spread: 15.00 (0.452%)
Market Cap: $875.98b
SMSD Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gds Share Chart

  • This share is an international stock.

2025 Capex Results

29 Jan 2026 07:52

RNS Number : 8913Q
Samsung Electronics Co. Ld
29 January 2026
 

Announcement of Capex Result for FY 2025

 

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) on January 29, 2025, announced its capital expenditure of approximately KRW 52.7 trillion.

 

Details

Purpose

To increase competitiveness of key businesses

Amount

- Total capex: approximately KRW 52.7 trillion

·  Device Solutions: KRW 47.5 trillion

·  Samsung Display Corp: KRW 2.8 trillion

Period

Jan 1, 2025-Dec 31, 2025

 

Details

- DS: investments to transition to advanced processes for high-value- added products, upgrade current lines, etc.

- SDC: investments to upgrade current lines, etc

Expected effect

Strengthen business capabilities by solidifying technology leadership, primarily in the component business

 

The capital expenditure plan is subject to change based on market conditions. The statements contained herein, including management's plan to make capital investments and expenditures (including but not limited to, in the amount and business segments referenced above), include statements of future expectations and other forward-looking statements that are based on management's current views, expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual investments and/or expenditures to differ materially from those expressed or implied in such statements. Actual investments or expenditures (including, but not limited to, the amount, timing or business segment), performance or events may differ materially from those in such statements due to, without limitation, (i) general economic conditions, including in particular economic conditions in Samsung Electronics Co., Ltd's ("SECL") core businesses and core markets, (ii) performance of financial markets, including emerging markets, and including market volatility, liquidity and credit events, (iii) currency exchange rates, (iv) changing levels of competition, (v) changes in laws and regulations, (vi) general competitive factors, in each case on a local, regional, national and/or global basis. The matters discussed herein may also be affected by risks and uncertainties described from time to time in SECL's filings with the Korea Stock Exchange (KRX), FSS (Korea), and Samsung Website. Further information about risks and uncertainties affecting Samsung Electronics Co., Ltd. is included throughout our most recent annual and interim reports, as well as our most recent earnings release, which are available on https://www.samsung.com/us/aboutsamsung/ir/newsMain.do. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual capital expenditures and investments (including, but not limited to, the area, timing, industry and amount) may vary materially from the announced capital expenditure plan and those described in the relevant forward-looking statement (if any), and all such statements and plan are subject to certain risks and uncertainties that could cause our actual investments and expenditures to be materially different from those expressed herein. The company assumes no obligation to update any forward-looking statement, including the capital expenditure plan.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZGZMNLGGVZG
12
Date   Source Headline
1st Jun 20268:51 amRNSCorporate Governance Report FY2025
29th May 20269:45 amRNS2026 1Q Interim Business Report
30th Apr 20269:03 amRNS2025 Business Report
30th Apr 20268:51 amRNSTransaction with Affiliate Company
30th Apr 20267:49 amRNSQuarterly Dividend for First Quarter 2026
30th Apr 20267:47 amRNS2026 1Q Earnings Release
24th Apr 20269:30 amRNSReport on Share Repurchase Results
7th Apr 20268:31 amRNSNotice of 1Q 2026 Earnings Release Schedule
7th Apr 20268:31 amRNS1Q 2026 Pre-Earnings Guidance
31st Mar 20268:32 amRNSDecision on Cancellation of Shares
25th Mar 20268:28 amRNSReport on Share Disposition Results
19th Mar 20267:46 amRNSSamsung Electronics Corporate Value Enhancement
18th Mar 20268:38 amRNSCharitable Contribution
18th Mar 20268:28 amRNSDecision on Share Disposition
18th Mar 20268:28 amRNSDecision on Share Repurchase
18th Mar 20268:28 amRNSResults of the 57th Annual General Meeting
12th Mar 20267:55 amRNSAdditional information about Ref. Material(AGM)
12th Mar 20267:55 amRNSAdditional information about Ref. Material(AGM)
12th Mar 20267:47 amRNSReport on Share Repurchase Results
12th Mar 20267:47 amRNSReport on Share Repurchase Results
25th Feb 20267:00 amRNSReplacement of Reference Material for 2026 AGM
13th Feb 20267:44 amRNSCharitable Contributions
13th Feb 20267:43 amRNSReference Material for 2026 AMG
12th Feb 202610:04 amRNS2025 Consolidated Financial Statements
12th Feb 202610:03 amRNS2025 Separate Financial Statements
4th Feb 20268:50 amRNSReport on Share Disposition Results
29th Jan 20268:25 amRNSReport on Share Disposition Results
29th Jan 20268:24 amRNSDecision on Share Disposition
29th Jan 20268:23 amRNSDecision on Share Repurchase
29th Jan 20267:52 amRNS2025 Capex Results
29th Jan 20267:52 amRNSYear-End Dividend for FY2025
29th Jan 20267:00 amRNS2025 4Q Earnings Release
27th Jan 20268:20 amRNSReport on Share Repurchase Results
26th Jan 20267:00 amRNSDecision on Share Disposition
8th Jan 20268:23 amRNSNotice of 4Q 2025 Earnings Release Schedule
8th Jan 20268:23 amRNS4Q 2025 Pre-Earnings Guidance
7th Jan 202610:28 amRNSDecision on Share Repurchase
28th Nov 20258:32 amRNS2025 3Q Interim Business Report
28th Nov 20258:29 amRNSTransaction with Affiliate Company
28th Nov 20258:27 amRNSAppointment of New Chief Executive Officer
28th Nov 20258:27 amRNSCharitable Contribution
5th Nov 20258:19 amRNSReport on Share Disposition Results
30th Oct 20258:16 amRNSDecision on Share Disposition
30th Oct 20257:58 amRNSCharitable Contribution
30th Oct 20257:58 amRNSAnnouncement of Capex Plan for FY 2025
30th Oct 20257:56 amRNSQuarterly Dividend for Third Quarter 2025
30th Oct 20257:00 amRNS2025 3Q Earnings Release
14th Oct 20258:44 amRNSNotice of 3Q 2025 Earnings Release Schedule
14th Oct 20258:42 amRNS3Q 2025 Pre-Earnings Guidance
2nd Oct 20259:02 amRNSReport on Share Repurchase Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.